Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2017 Dec 13;293(4):1259–1270. doi: 10.1074/jbc.M117.812206

Authentic CRAC channel activity requires STIM1 and the conserved portion of the Orai N terminus

Isabella Derler 1,1, Carmen Butorac 1, Adéla Krizova 1, Michael Stadlbauer 1, Martin Muik 1, Marc Fahrner 1, Irene Frischauf 1, Christoph Romanin 1,2
PMCID: PMC5787803  PMID: 29237734

Abstract

Calcium (Ca2+) is an essential second messenger required for diverse signaling processes in immune cells. Ca2+ release-activated Ca2+ (CRAC) channels represent one main Ca2+ entry pathway into the cell. They are fully reconstituted via two proteins, the stromal interaction molecule 1 (STIM1), a Ca2+ sensor in the endoplasmic reticulum, and the Ca2+ ion channel Orai in the plasma membrane. After Ca2+ store depletion, STIM1 and Orai couple to each other, allowing Ca2+ influx. CRAC-/STIM1-mediated Orai channel currents display characteristic hallmarks such as high Ca2+ selectivity, an increase in current density when switching from a Ca2+-containing solution to a divalent-free Na+ one, and fast Ca2+-dependent inactivation. Here, we discovered several constitutively active Orai1 and Orai3 mutants, containing substitutions in the TM3 and/or TM4 regions, all of which displayed a loss of the typical CRAC channel hallmarks. Restoring authentic CRAC channel activity required both the presence of STIM1 and the conserved Orai N-terminal portion. Similarly, these structural requisites were found in store-operated Orai channels. Key molecular determinants within the Orai N terminus that together with STIM1 maintained the typical CRAC channel hallmarks were distinct from those that controlled store-dependent Orai activation. In conclusion, the conserved portion of the Orai N terminus is essential for STIM1, as it fine-tunes the open Orai channel gating, thereby establishing authentic CRAC channel activity.

Keywords: calcium channel, calcium release-activated calcium channel protein 1 (ORAI1), electrophysiology, signal transduction, stromal interaction molecule 1 (STIM1), calcium-dependent inactivation, sodium permeation

Introduction

Calcium (Ca2+) represents an important second messenger that is indispensable for various signaling processes in immune and other types of cells (13). The Ca2+ release-activated Ca2+ (CRAC)3 channel, which is activated following intracellular Ca2+ store depletion, represents one main Ca2+ entry pathway (4, 5).

CRAC channels are fully reconstituted via two proteins, the stromal interaction molecule 1 (STIM1) and Orai (512). STIM1 represents an endoplasmic reticulum (ER)-located Ca2+sensing protein (6, 7, 13), whereas Orai forms the Ca2+-selective ion channel in the plasma membrane (58, 1417). Upon depletion of Ca2+ from the ER, STIM1 proteins oligomerize, move into discrete puncta at the plasma membrane (PM)-ER junctions, and couple to and activate Orai channels (16, 1821). Subsequently, Ca2+ permeates the Orai channel to enter the cell (22, 23).

The Orai protein family includes three members, Orai1–3. They are all composed of cytosolic N- and C-terminal strands and four transmembrane domains (TM) connected via intracellular (TM2-TM3) or extracellular (TM1-TM2 and TM3-TM4) loops (17, 24, 25). Both N and C termini are required for STIM1-dependent Orai channel activity (20, 22, 2630). The Orai C terminus forms the main binding site for STIM1 (20), whereas direct STIM1 binding to the N terminus is currently controversial (31).

Based on the crystal structure of Drosophila Orai, Orai Ca2+ ion channels are assumed to form hexameric complexes (32). STIM1-induced Orai channel pore opening involves a rotation of the hydrophobic region in TM1. However, it has so far remained unclear how this conformational change takes place. Mutagenesis studies have revealed that certain amino acids, like Gly98, Phe99, Val102, and Val107 in TM1 (3336), but also other TM residues, such as Leu138 (37), Trp176 (38), Thr184 (36), and Pro245 (28), or residues between TM4 and the C terminus (i.e. Leu261-Val262-His264-Lys265) (31) contribute to the maintenance of the closed state, as their point mutation leads to constitutively open channels. For this reason, it has been hypothesized that the open state is established upon global rearrangement of TM helices after STIM1 binding (28, 39, 40).

CRAC/Orai channel currents exhibit a strongly inwardly rectifying current/voltage relationship with a reversal potential higher than +50 mV (41, 42), which indicates one typical CRAC channel hallmark. The permeability for Ca2+ is 1000 times larger than for Na+ (43). Orai channels conduct small monovalent ions, such as Na+, Li+, or K+, as long as the monovalent solution lacks divalent ions. Monovalent Orai currents are inhibited by Ca2+ concentrations in the micromolar range (4348). Upon the switch from a Ca2+-containing to a divalent-free (DVF) Na+-containing solution, CRAC/Orai currents have been reported to increase 5-fold or even more (42, 46, 4951), displaying another prominent CRAC channel hallmark. Orai channels are almost impermeable for the monovalent ion Cs+ because of Orai's very narrow pore diameter (46, 52). Due to CRAC channels' very low single channel conductance in the range of 1 picosiemens, single-channel current measurements have not been feasible so far. Recently, however, single-channel open states were visualized via optical recordings employing Orai1 proteins fused to a genetically encoded calcium indicator (53).

Another typical hallmark of Orai/CRAC channels represents fast Ca2+-dependent inactivation (FCDI), which reduces Ca2+ entry and thus displays an important feedback mechanism to tightly control intracellular Ca2+ concentrations (43, 54). FCDI occurs in all three Orai channels within the first 100 ms of a voltage step and more often happens in Orai3 compared with Orai1 or Orai2 (42, 55, 56). In Orai1, FCDI is followed by a late reactivation phase over the next 2 s, in contrast to Orai2 and Orai3 channels, which subsequently show a slower inactivation phase (42, 55).

In our study, which focused on these three CRAC channel hallmarks, we discovered that several constitutively active Orai1 and Orai3 mutants displayed authentic CRAC channel activity, but only in the presence of STIM1 and the conserved portion of the Orai N terminus. The structural requirements for STIM1 within this conserved N terminus were identical in constitutively active as well store-operated Orai channels.

Results

Maintaining CRAC channel permeation characteristics of constitutively active Orai mutants requires STIM1

One of the major hallmarks of CRAC channel permeation is the increase in current density when switching from a Ca2+-containing to a DVF Na+-containing solution, as exemplified for wildtype Orai1 as well as wildtype Orai3, each co-expressed with STIM1 (Fig. S1). Here we focused on several constitutively active Orai1 and Orai3 channels, the activity of which become STIM1-independent by mutating one or two residues in TM3 and/or TM4. For Orai1, we specifically examined the Orai1 L185A (TM3)/F250A (TM4) double and the Orai1 P245L (TM4) single mutant, where the latter is associated with tubular myopathy (57). Both Orai1 mutants gave rise to robust, constitutive activity without STIM1 being co-expressed (Fig. 1), and they exhibited considerable yet somewhat reduced Ca2+ selectivity (see Fig. 2 and Fig. S2) in a 10 mm Ca2+-containing extracellular solution, when compared with the wildtype CRAC current. Strikingly, when testing for authentic CRAC channel permeation characteristics by switching from the Ca2+ to a DVF Na+-containing solution, a clear decrease in current density occurred with each constitutively active Orai1 channel mutant (Fig. 1 (a–e) and Fig. S2), in sharp contrast to what was seen in wildtype CRAC channels (compare with Fig. S1). Co-expression of these constitutively active Orai1 channel mutants with STIM1, however, dramatically altered their response to DVF Na+-containing solution, given that the expected ∼5-fold increase in current density (Fig. 1e) occurred in line with the hallmark of wildtype CRAC channels. Although we have only seldom detected the reported (4345, 47) deactivation of STIM1/Orai-mediated Na+ currents, which is probably due to a slow solution exchange, these STIM1-dependent, maximum current increases of constitutively active Orai mutants in DVF solution have been seen in both N-terminally and C-terminally labeled mutants. It was exemplarily shown for Orai1 P245L (Fig. S3, a–c), thus excluding any side effect from the label. Constitutive Orai1 currents were not distorted by endogenous STIM1, as overexpression of constitutive Orai1 mutants in CRISP/Cas9 STIM1 knockout HEK cells revealed comparable behaviors whether in the absence or presence of STIM1, as exemplarily shown for Orai1 P245L (Fig. S4, a–c). Furthermore, disruption of potential STIM1 binding by the introduction of the Orai1 L273D C-terminal mutation (58) did not alter activity, as exemplified by the Orai1 P245L/L273D mutant expressed in HEK 293 cells (Fig. S4, d–h).

Figure 1.

Figure 1.

CRAC channel permeation characteristics of constitutively active mutants are maintained in the presence of STIM1. Shown are schemes illustrating Orai channels with the respective mutations tested: L185A/F250A and P245L in Orai1 and F160A and P254L in Orai3. a, c, f, and h, respective time courses of whole-cell inward currents at −74 mV of constitutively active mutants Orai1 L185A/F250A (a), Orai1 P245L (c), Orai3 F160A (f), and Orai3 P254L (h) in the absence compared with the presence of STIM1. At t = 0 s, inward currents in 10 mm extracellular Ca2+ solution activated upon passive store depletion via 20 mm EGTA are shown after reaching a steady-state level, and after 100 s, Na+-DVF solution was perfused. b, d, g, and i, block diagram exhibiting current density at 50 and 150 s of tested mutants (a, c, f, and h) with and without STIM1. e and j, block diagram exhibiting the ratio of IDVF versus ICa2+ of tested mutants with and without STIM1 (a, c, f, and h). Error bars, S.E.; *, p < 0.05.

Figure 2.

Figure 2.

Maintenance of typical CRAC channel I/V relationships of constitutively active Orai mutants requires STIM1. a, b, d, and e, normalized I/V relationships of mutants tested in Fig. 1 in the absence compared with the presence of STIM1. c and f, reversal potentials of the respective mutants in a, b, d, and e. Error bars, S.E.; *, p < 0.05.

To assess the Orai isoform specificity of the observed dependence on permeation characteristics in the presence of STIM1, we further tested two constitutively active Orai3 channel mutants (i.e. Orai3 F160A and Orai3 P254L). The latter represented the analogue of Orai1 P245L, and both exhibited robust, constitutive activity in the absence of STIM1. As with the Orai1 mutants, switching from the Ca2+-containing to the DVF Na+-containing solution resulted in a decrease of current density in the absence of STIM1, whereas in the presence of STIM1, current densities were increased (Fig. 1, f–j), as expected for CRAC channel–like hallmarks.

Hence, authentic CRAC channel behavior of constitutively active Orai1 or Orai3 isoforms with respect to di-/monovalent permeation characteristics required their coupling to STIM1. Overall, the results indicate that the Orai channel open state elicited by specific point mutations in TM3 and/or TM4 retained CRAC channel-like permeation properties only in the presence of STIM1.

STIM1 is required to maintain authentic CRAC channel current/voltage relationship

CRAC currents typically display a strongly inwardly rectifying current/voltage (I/V) relationship with a positive slope conductance at negative potentials and a reversal potential higher than +50 mV. Fig. 2 displays the I/V relationships of the constitutively active Orai1 and Orai3 mutants, introduced in Fig. 1, both in the absence and presence of STIM1. Voltage ramps over a duration of 1 s were applied at a holding potential of 0 mV, ranging from −90 to +90 mV, and for better comparison, the depicted I/V relationships were normalized to −1 at −85 mV. All Orai channel mutants exhibited strongly inwardly rectifying current/voltage relationships without STIM1 co-expressed; however, they revealed a U-shaped form at very negative potentials between −85 and −70 mV (Fig. 2). The reversal potentials of the Orai1 and Orai3 mutants were in the range of ∼+35 and ∼+48 mV, respectively, with the Orai1 mutants typically exhibiting lower reversal potentials than Orai3 (Fig. 2, c and f). In the presence of STIM1, the I/V relationships regained inward rectification similar to that of wildtype STIM1/Orai1 and STIM1/Orai3 currents together with a rightward shift of the reversal potentials toward ∼+50 mV comparable with authentic CRAC channel currents (Fig. 2). The U-shaped characteristic of the I/V relationship of constitutively active mutants in the absence of STIM1 was not visible in a faster voltage ramp over 200 ms, as exemplarily shown for Orai3 F160A (Fig. S5), pointing to a mechanism that evolved at the time scale of 1 s (see below). Nonetheless, the permeation characteristics of Orai3 F160A when switching from an extracellular to a DVF solution similarly exhibited a dependence on STIM1, with a current decrease and increase in the absence and presence of STIM1, respectively. This indicated that the persistence of this CRAC channel hallmark was not dependent on the duration of the applied voltage ramp (Fig. S5).

In summary, constitutively active TM3 and TM4 Orai1 as well as Orai3 point mutants displayed inwardly rectifying I/V relationships with an unusual, U-shaped characteristic, as revealed by voltage ramps of 1-s duration. Only the presence of STIM1 readjusted I/V relationships both in form and reversal potential toward those of the wildtype forms. Next, we checked whether this U-shaped form in current/voltage relationships might be related to a change of current inactivation profiles.

Ca2+-dependent Orai inactivation necessitates STIM1

FCDI provides negative feedback to CRAC channels, a unique hallmark that is seen with both STIM1-activated Orai1 and Orai3 isoforms (Fig. S1, f and l). FCDI of the constitutively active Orai1/3 mutants was completely abolished in the absence of STIM1 (Fig. 3, a–d). Moreover, inactivation was not only blunted but was reversed into a robust potentiation, reaching a plateau between 500 and 1000 ms during a 1500-ms voltage step to −70 mV applied from a holding potential of 0 mV. The co-expression of STIM1 with these mutants fully restored FCDI to a level comparable with that of wildtype STIM1-mediated Orai1 and Orai3 currents (Fig. 3, a–d).

Figure 3.

Figure 3.

CRAC channel-like inactivation of constitutively active Orai mutants requires STIM1. a–d, inactivation characteristics of constitutively active mutants shown in Figs. 1 and 2 in the absence compared with the presence of STIM1. Error bars, S.E.

In aggregate, constitutively active Orai1 and Orai3 TM3/TM4 mutants required STIM1 coupling to retain the typical FCDI characteristics of authentic CRAC channels. Overall, STIM1 was indispensable in conveying the plethora of CRAC channel hallmarks onto the constitutively active Orai1/Orai3 channels, despite their propensity of STIM1-independent gating.

STIM1 fails in maintaining CRAC channel hallmarks of constitutively active Orai channels with substantial N-terminal deletion

Next, we investigated the role of the N terminus, with a focus on the conserved N-terminal region, the so-called extended transmembrane Orai N-terminal (ETON) region (see Fig. 4 (top)), in the maintenance of CRAC channel characteristics of these constitutively active Orai mutants by generating analogue N-terminal deletions in both Orai1 and Orai3. We and others (27) have reported that among analogue Orai N-terminal deletion mutants (i.e. Orai1 ΔN1–78 and Orai3 ΔN1–53, only that of Orai3 remains functional upon STIM1-dependent activation (29). Correspondingly, when truncating the N terminus of the constitutive Orai mutants, the activity of Orai1 ΔN1–78 L185A/F250A and P245L mutants was abolished (65), whereas the analogue Orai3 N-terminal deletion mutants (Orai3 ΔN1–53 F160A and P254L) were still active (see Fig. 4, k and p). Although this has been interpreted (29, 59) as distinct N-terminal structural requirements in the STIM1-dependent activation of Orai1 and Orai3, the results in the accompanying paper (65) revealed that activation of non-functional Orai1 N-truncation mutants could be regained by switching loop2 with that of Orai3 (L2 aa 119–147). Because similar behavior was observed with the constitutively active Orai1 L185A/F250A and P245L mutants (see Fig. 4), the respective functional Orai1 Orai3-L2 chimeras were employed for comparison of the maintenance of CRAC channel hallmarks of Orai1 and Orai3 N-truncation mutants. Side effects from the swap of loop2 can be largely excluded, as full-length Orai1 Orai3-L2 and Orai1 Orai3-L2 P245L each co-expressed with STIM1 showed the expected current increases when switching from Ca2+ to DVF Na+ solution (Fig. S6, a and b).

Figure 4.

Figure 4.

STIM1 fails in maintaining CRAC channel hallmarks of constitutively active Orai channels with substantial N-terminal deletions. Shown is a sequence alignment of Orai1 and Orai3 N terminus highlighting N-terminal residues at which the Orai N terminus was truncated. Shown are schemes illustrating the Orai channels with the respective mutations tested: Orai1 ΔN1–78 L185A/F250A Orai3-L2, Orai1 ΔN1–78 P245L Orai3-L2, Orai3 ΔN1–53 F160A, and Orai3 ΔN1–53 P254L. a, f, k, and p, respective time courses of whole-cell inward currents at −74 mV of constitutively active mutants: Orai1 ΔN1–78 L185A/F250A Orai3-L2 (a), Orai1 ΔN1–78 P245L Orai3-L2 (f), Orai3 ΔN1–53 F160A (k), and Orai3 ΔN1–53 P254L (p) in the absence compared with the presence of STIM1. At t = 0 s, inward currents in 10 mm extracellular Ca2+ solution activated upon passive store-depletion via 10 mm EGTA are shown after reaching a steady-state level, and after 100 s, Na+-DVF solution was perfused. b, g, l, and q, block diagram exhibiting current density at 50 and 150 s of tested mutants without and with STIM1 (a, f, k, and p). c, h, m, and r, block diagram exhibiting the ratio of IDVF versus ICa2+ of tested mutants without and with STIM1 (a, c, k, and p). d, i, n, and s, block diagram exhibiting the reversal potentials of the respective mutants in the absence compared with the presence of STIM1. e, j, o, and t, inactivation characteristics of constitutively active mutants shown in this figure in the absence compared with the presence of STIM1. Error bars, S.E.; *, p < 0.05; n.s., not significant.

Examination for the typical CRAC channel hallmarks of the constitutive Orai N-truncation mutants (Orai1 ΔN1–78 Orai3-L2 L185A F250A, Orai1 ΔN1–78 Orai3-L2 P245L, Orai3 ΔN1–53 F160A, and Orai3 ΔN1–53 P254L), both with and without STIM1, revealed that neither the increase in current size with DVF solution (Fig. 4, a–d, f–i, k–n, and p–s) nor the inactivation profile (Fig. 4, e, j, o, and t) was restored by the presence of STIM1, when a substantial portion of the Orai1 or Orai3 N terminus was missing. We confirmed coupling of Orai truncation mutants to STIM1 C-terminal fragments, as fluorescence intensity measurements revealed that co-localization was retained although somewhat reduced, as exemplarily shown of Orai3 ΔN1–53 F160A and the Orai1-activating STIM1 fragment (OASF) (Fig. S7).

In summary, all of the constitutively active Orai1 and Orai3 mutants with corresponding N-terminal deletions lacked the CRAC channel hallmarks, both in the absence and presence of STIM1. These results suggested that N-terminal residues located upstream of Lys78 in Orai1 and Arg53 in Orai3 were required for the STIM1-dependent maintenance of these CRAC channel hallmarks.

The conserved ETON portion is required to maintain the CRAC channel hallmarks of constitutively active mutants in the presence of STIM1

Next, we investigated in more detail to what extent the conserved ETON region (see Fig. 5 (top)) is required for maintaining the typical CRAC channel hallmarks in the presence of STIM1. We examined less pronounced N-truncations of constitutively active Orai1 channels with increasing deletions of ΔN1–72 and ΔN1–74. Orai1 ΔN1–72 L185A/F250A displayed authentic CRAC channel characteristics in the presence of STIM1 (Fig. 5a). Specifically, current densities increased following the DVF solution switch (Fig. 5, a–e), and current responses to voltage steps showed almost no potentiation, comparable with wildtype Orai channels (Fig. 5c). In contrast, the further deletion of two additional N-terminal residues (i.e. Orai1 ΔN1–74 L185A/F250A) led to a loss of these CRAC channel hallmarks in the presence of STIM1, resulting in substantially decreased current responses to DVF solution concomitant to a strong current potentiation (Fig. 5, a–e). Corresponding (Orai3 residues 47/49 correspond to Orai1 72/74) N-terminal deletions in Orai3 (Orai3 ΔN1–47/49 F160A) already resulted in a loss of the typical CRAC channel hallmarks for both constitutively active mutants in the presence of STIM1. However, N-terminal deletion, including residue 46, generated the mutant Orai3 ΔN1–46 F160A that retained all of the typical CRAC current hallmarks (Fig. 5, f–j). Thus, Orai3, in comparison with Orai1, needed the presence of one additional N-terminal residue upstream to the conserved N-terminal region to retain the typical CRAC channel characteristics (see alignment in Fig. 5 (top)).

Figure 5.

Figure 5.

Constitutively active Orai channels require the whole conserved ETON region to maintain CRAC channel hallmarks. Shown are schemes illustrating the Orai channels with the respective mutations tested: Orai1 ΔN1–72/74 L185A/F250A and Orai3 ΔN1–46/47/49 F160A. a and f, respective time courses of whole-cell inward currents at −74 mV of constitutively active mutants: Orai1 ΔN1–72/74 L185A/F250A (a) and Orai3 ΔN1–46/47/49 F160A (f) in the absence compared with the presence of STIM1. At t = 0 s, inward currents in 10 mm extracellular Ca2+ solution activated upon passive store depletion via 10 mm EGTA are shown after reaching a steady-state level, and after 100 s, Na+-DVF solution was perfused. b and g, block diagram exhibiting current density at 50 and 150 s of tested mutants without and with STIM1 (a and f). c and h, block diagram exhibiting the ratio of IDVF versus ICa2+ of tested mutants without and with STIM1 (a and f). d and i, block diagram exhibiting the reversal potentials of mutants tested in a and f in the absence compared with the presence of STIM1. e and j, inactivation characteristics of constitutively active mutants shown in this figure in the absence compared with the presence of STIM1. Error bars, S.E.; *, p < 0.05; n.s., not significant.

In summary, the regulatory impact of STIM1 in conferring CRAC channel hallmarks to constitutively active TM3/TM4 Orai1 and Orai3 mutants required at least the presence of the whole, conserved N-terminal region (Orai1 aa 73–90; Orai3 aa 48–65) and, in the case of Orai3, one more upstream residue.

Store-operated Orai channels exhibit identical structural N-terminal requirements to maintain authentic CRAC channel activity in the presence of STIM1

In the following, we investigated whether store-operated Orai channels that were activated via STIM1 displayed authentic CRAC channel characteristics with the N-terminal deletions (see alignment in Fig. 6 (top)) previously identified with the constitutively active forms. Whereas STIM1-dependent currents of Orai1 ΔN1–71 or ΔN1–72 displayed the expected, yet less pronounced increase in current density upon switching from the Ca2+ to the DVF solution, Orai1 ΔN1–74 channels had already yielded a decrease (Fig. 6, a–c), consistent with the corresponding, constitutively active Orai1 mutants (see Fig. 5 (a–c)). Similarly, only Orai3 ΔN1–46 retained these typical CRAC hallmarks, whereas further N-terminal deletions to 47 and 49 resulted in reduced currents in DVF solution. Co-localization and FRET with STIM1-OASF was accordingly enhanced for Orai1 ΔN1–72 and Orai3 ΔN1–46 compared with Orai1 ΔN1–74 and Orai3 ΔN1–47, respectively (Fig. 6, e, f, k, and l). Interestingly, FCDI assessed by the response to a voltage step was not that much different between the Orai1 N-terminal deletion mutants, whereas the Orai3 N-terminal deletions with reduced currents in DVF solution exhibited the expected current potentiation (Fig. 6, d and i).

Figure 6.

Figure 6.

STIM1-dependent store-operated Orai channel activation requires identical N-terminal portions as constitutively active Orai mutants to maintain CRAC channel hallmarks. Shown is the sequence alignment of Orai1 (aa 68–110) and Orai3 (aa 43–115) in a comparison exhibiting which segments are required for maintenance of CRAC channel hallmarks. a and g, respective time courses of whole-cell inward currents at −74 mV of Orai1 ΔN1–71/72/74 (a) and Orai3 ΔN1–46/47/49 (g) in co-expression with STIM1. Inward currents activated upon passive store depletion via 10 mm EGTA are shown in 10 mm extracellular Ca2+ solution. After they reached a steady-state level at 150 s, Na+-DVF solution was perfused. b and h, block diagram exhibiting the ratio of IDVF versus ICa2+ of tested mutants without and with STIM1 (a and f). c and i, block diagram exhibiting the reversal potentials of mutants tested in a and f in the absence compared with the presence of STIM1. d and j, inactivation characteristics of constitutively active mutants shown in this figure in the absence compared with the presence of STIM1. e and k (left), intensity plots representing the localization of STIM1 OASF (aa 233–474) across the cell when co-expressed with Orai1 ΔN1–72 compared with Orai1 ΔN1–74 (e) and Orai3 ΔN1–46 compared with Orai3 ΔN1–47 (k). Right, block diagram exhibits corresponding mean and single values for normalized intensities at time point indicated by an arrow in the intensity plots on the left. f and l (left), image series depicting CFP-OASF and YFP-Orai1, -Orai1 ΔN1–78, or Orai1 ΔN1–78 Orai3-L2, overlay and pixelwise calculated NFRET index for a representative cell. Right, the yellow arrows denote plasma membrane localization. A block diagram exhibits mean NFRET determined from the averages of whole-cell areas for the respective number of cells expressing the depicted constructs. Bars, 5 μm. Error bars, S.E.; *, p < 0.05; n.s., not significant.

The finding that Orai1 required one amino acid less than Orai3 to maintain CRAC channel hallmarks suggested isoform-specific N-terminal requirements. In an attempt to understand this phenomenon, we utilized N-truncated Orai1 chimeras containing Orai3-L2 to mimic the Orai3 background. All generated N-truncated Orai1 Orai3-L2 chimeras with increasing deletions (Orai1 Orai3-L2 ΔN1–71, ΔN1–72, ΔN1–74, and ΔN1–78) lost their typical CRAC channel characteristics, which is in line with analogue Orai3 N-truncation mutants, except for Orai1 ΔN1–71 Orai3-L2 (Fig. S8). The latter was in contrast to the analogue Orai3 ΔN1–46, which exhibited enhanced IDVF versus ICa2+. Here, introducing the single point mutation Q72R into Orai1 Orai3-L2 ΔN1–71 to mimic the Orai3 N terminus portion restored typical CRAC channel characteristics (Fig. S8). These results further suggested communication between the Orai N-terminal region and Orai-L2 (see Ref. 65).

In aggregate, not only constitutive Orai mutants, but also store-operated Orai channels, required the presence of STIM1 and the analogue N-terminal portion to fully reconstitute CRAC channel hallmarks. In addition, the N-terminal portion necessary for these CRAC channel hallmarks was apparently longer than that required for retaining store-dependent activation (29, 59) (also see below).

Mutations within the Orai1 N-terminal conserved region perturb CRAC channel characteristics

In addition to the N-terminal truncation mutants, we further tested the effect of two selected N-terminal point mutants, L74E/W76E (29) and K85E (60), for their effect on the typical CRAC channel hallmarks. Because both mutations interfered with STIM1-dependent Orai1 activation, their role in controlling CRAC channel hallmarks was tested in an Orai1 template with either Orai3-L2 and/or P245L in an attempt to restore Orai1 mutant channel activity.

STIM1-mediated activation of Orai1 L74E/W76E was restored upon the swap of Orai1-L2 for Orai3-L2 (Orai1 L74E/W76E Orai3-L2). Moreover, Orai1 L74E/W76E became constitutively active upon introduction of P245L (Orai1 L74E/W76E/P245L). However, both mutants with restored activity did not display any CRAC channel hallmarks (Fig. 7, a–c) in the presence of STIM1, in contrast to Orai1 Orai3-L2 (Fig. S6a) and Orai1 P245L (Fig. 1), suggesting Leu74/Trp76 as critical N-terminal determinants in the maintenance of authentic CRAC channel activity.

Figure 7.

Figure 7.

N-terminal mutations within Orai1 perturb CRAC channel characteristics. Shown is the sequence alignment of Orai1 (aa 68–110) exhibiting key residues involved in the maintenance of CRAC hallmarks or store-operated activation. Shown are schemes illustrating the Orai channels with the respective mutations tested: Orai1 L74E/W76E Orai3-L2, Orai1 L74E/W76E/P245L, Orai1 K85E Orai3-L2, and Orai1 K85E/P245L Orai3-L2. a, b, d, and e, time courses of whole-cell inward currents at −74 mV of Orai1 L74E/W76E Orai3-L2 in comparison with Orai1 L74E/W76E (a), Orai1 K85E Orai3-L2 compared with Orai1 K85E (b), Orai1 L74E/W76E/P245L (d), and Orai1 K85E/P245L compared with Orai1 K85E/P245L Orai3-L2 (e) in co-expression with STIM1. Inward currents activated upon passive store depletion via 10 mm EGTA are shown in 10 mm extracellular Ca2+ solution. After they reached a steady-state level, Na+-DVF solution was perfused. c and f, inactivation characteristic of the mutants shown in a, b, d, and e. Error bars, S.E.

As progressive Orai1 N-truncations impaired initially the CRAC channel hallmarks followed by STIM1-dependent, store-operated activation, we further examined whether these features occurred independent of each other. Hence, we employed the K85E N-terminal point mutation, which interfered with STIM1-dependent activation (60), but left the rest of the N terminus intact. By swapping Orai1-L2 for Orai3-L2 in Orai1 K85E, we succeeded in slightly restoring STIM1-induced current activation (Fig. 7b), providing the opportunity to test for the CRAC channel hallmarks. Orai1 K85E Orai3-L2 displayed authentic CRAC channel characteristics comparable with Orai1 Orai3-L2 or wildtype Orai1 (Fig. S6a), in contrast to Orai1 L74E/W76E Orai3-L2. Furthermore, whereas Orai1 K85E/P245L remained inactive, an additional swap of Orai3-L2 (Orai1 K85E/P245L Orai3-L2) restored channel activation upon STIM1 co-expression, not in a constitutive but in a store-operated manner. Here, Orai1 K85E/P245L Orai3-L2 also exhibited fully preserved authentic CRAC channel hallmarks (Fig. 7, d–e), comparable with Orai1 P245L or Orai1 P245L Orai3-L2 in the presence of STIM1. Hence, whereas the extent of STIM1-dependent activity of Orai1 K85E can only be marginally restored by P245L or Orai3-loop2, the CRAC channel hallmarks remained unaffected by K85E localized to the second half of the conserved Orai1 N-terminal region (see alignment in Fig. 6 (top)).

In summary, we determined that distinct Orai1 N-terminal domains control typical CRAC channel characteristics and store-operated activation. Whereas the two N-terminal residues Leu74 and Trp76 were required to maintain the CRAC channel hallmarks, they were insignificant for store-operated STIM1-dependent activation. Lys85, however, controlled store-operated activation of Orai1 channels but did not affect the CRAC channel hallmarks. Thus, maintenance of the typical CRAC channel hallmarks required the first half of the conserved N-terminal region, whereas the second half was imperative for store-operated CRAC channel activation.

Discussion

The constitutively active Orai TM3/TM4 mutants did not recapitulate authentic CRAC channel activity, which included reduced Ca2+ selectivity, distinctly different current responses to DVF-Na+ solution, and a lack of FCDI. Restoration of these CRAC channel hallmarks was obtained by coupling to STIM1 but failed when the conserved portion of Orai N terminus (ETON region) was either truncated or mutated. Generally, maintaining authentic CRAC channel activity required the presence of both STIM1 and the ETON region, not only with the constitutively active Orai mutants but also with wildtype Orai channels.

Although the constitutive TM3/TM4 Orai mutants presented here exhibited modestly reduced Ca2+ selectivity, they were much more selective than the constitutively active Orai1 V102A (34) form. CRAC channel-like Ca2+ selectivity could be restored by the presence of STIM1, as is common for these constitutively active Orai1 mutants. This high Ca2+ selectivity, also found in wildtype Orai1 channels, is ensured as long as a sufficient amount of STIM1 is bound (34). Additionally, STIM1 is indispensable for FCDI of Orai channels. In the absence of STIM1, the constitutively active TM3/TM4 Orai mutants completely lacked FCDI. Moreover, currents exhibited strong potentiation in response to a voltage step, reaching a plateau after 1500 ms, as consistently observed with other constitutively active Orai1 channels (34, 40). This potentiation apparently involved a Ca2+-dependent process, as it was observed neither with Ba2+ nor with Na+ as charge carriers, as exemplarily shown with Orai3 F160A (Fig. S9, a and b). Hence, STIM1 reverses this potentiation into FCDI, thereby limiting physiological Ca2+ entry into the cell, re-establishing this hallmark of authentic CRAC channel activity.

The current increase when switching from the Ca2+ to the DVF Na+ solution represented another hallmark of authentic CRAC channel activity, which was drastically altered with the constitutively active TM3/TM4 mutant Orai channels in the absence of STIM1. Until now, several other TM1/TM2/TM3 Orai1 mutants like Orai1 G98D/S (33, 61), Orai1 F99S/M/Y (61), Orai1 V102C/A (34), Orai1 V107M (36), Orai1 L138F (37), Orai1 W176C (38), and Orai1 T184M (36) have been reported to induce constitutive activity in the absence of STIM1. Among those that have been examined for permeation in DVF Na+ solution, current increases are obtained with the Orai1 G98S, Orai1 F99Y, Orai1 V102A, and Orai1 W176C mutants (34, 61) upon the switch from a Ca2+- to Na+-containing solution. This is in contrast to what we observed with the constitutively active Orai TM3/TM4 mutants studied here. Hence, Na+ permeation of the former Orai1 mutants is not substantially hampered, possibly due to a better stabilization of the Orai1 channel open state, whereas the latter TM3/TM4 mutants studied here required both the presence of STIM1 and the conserved Orai N-terminal portion. The switch from a Ca2+-containing to a DVF Cs+-containing solution revealed current reductions for our Orai TM3/TM4 mutants, as exemplarily shown for Orai3 F160A in line with the lack of Cs+ permeation of typical CRAC currents (Fig. S9, c and d). In contrast, Orai1 V102A is permeable for Cs+ (34), which suggests a larger pore diameter for Orai1 V102A compared with Orai1 TM3/TM4 constitutive point mutants. The Orai1 V102A mutant consistently retains constitutive activity even with extensive N-terminal truncations (27, 29, 34, 40).

Only the fully conserved ETON region in Orai1 (aa 73–90) and in Orai3 (aa 47–65) could retain authentic CRAC channel activity by STIM1, as was the case in constitutively active as well as store-operated Orai channels. Even N-terminal truncations within this region that did not affect the principal activity were typically accompanied by the loss of STIM1-dependent CRAC channel hallmarks such as current increases in DVF Na+-containing solution and FCDI. Within this conserved N-terminal region in Orai1, Leu74 and Trp76, among other residues, played an important role, as their mutation similarly led to a loss of these CRAC channel hallmarks. However, the general activity of Orai channels, induced either via STIM1 or TM3/TM4 point mutations in a store-dependent or constitutive manner, respectively, only required the presence of the latter 10 residues (Orai1 aa 80–90; Orai3 aa 55–65) (29, 59) of the conserved N-terminal region. In line with this, introduction of the K85E mutation in full-length Orai1 that substantially impaired the STIM1-dependent, general Orai1 activity did not affect the typical CRAC channel hallmarks. Hence, distinct domains within the conserved Orai N-terminal portion convey different functions to the overall CRAC channel activity. Whereas the latter stretch (Orai1 aa 80–90; Orai3 aa 55–65) contributes to the general activity, the former part (Orai1 aa 73–79; Orai3 aa 47–54) is key for the CRAC channel hallmarks in fine-tuning Ca2+ entry. It thus far remains unclear whether these regulatory events occur via STIM1 interaction with the conserved Orai N terminus region (20, 29, 39, 62) or in an allosteric manner, with the Orai1 C terminus triggering signal transmission through TM domain reorientations (31) or through involvement of other parts of the channel protein (61). Within this context, a permissive communication between the Orai1 N terminus and loop2 (see Ref. 65) is required for retaining Orai1 channel activity, particularly with Orai1 N-terminal truncations and mutations within the aa 73–79 domain.

In summary, STIM1 communication with the conserved portion of the Orai N terminus (ETON region) is essential for maintaining the typical CRAC channel hallmarks. Whereas point mutations in TM3/TM4 generate constitutively active Orai channels, authentic CRAC channel activity requires the presence of STIM1 and the ETON region, as is similar with wildtype Orai channels. STIM1 binding to the Orai channel mechanistically alters the overall conformation and orientation of TM helices, including the ETON region, to manifest authentic CRAC channel gating and open pore structure (40, 61, 62). For more detained resolution of the STIM-Orai complex, molecular dynamics simulations or single-particle cryo-EM are required.

Experimental procedures

Molecular biology

For N-terminal fluorescence labeling of human Orai1 (Orai1; accession number NM_032790, provided by the laboratory of A. Rao) as well as Orai3 (Orai3; accession number NM_152288, provided by the laboratory of L. Birnbaumer), the constructs were cloned into the pEYFP-C1 (Clontech) expression vector via KpnI and XbaI (Orai1) and BamHI and XbaI (Orai3) restriction sites, respectively. Orai1 N-terminal deletion mutants (Orai1 ΔN1–71, ΔN1–72, ΔN1–74, ΔN1–76, and ΔN1–78) were amplified via PCR, including an N-terminal KpnI and a C-terminal XbaI restriction site; Orai3 N-terminal deletion mutants (Orai3 ΔN1–46, ΔN1–47, ΔN1–49, and ΔN1–53) were amplified via PCR, including an N-terminal BamHI and a C-terminal XbaI restriction site for cloning into the pEYFP-C1 vector. Chimeric constructs (Orai1-Orai3-loop2 and Orai1 ΔN1–78-Orai3-loop2) were cloned via SOEing (Splicing by Overlap Extension) into the pEYFP-C1 (Clontech) expression vector for N-terminal fluorescence labeling. Site-directed mutagenesis (L185A/F250A, P245L, K85E/P245L, L74E/W76E/P245L, K85E, L74E/W76E, and P245L/L273S/D) was performed using the QuikChangeTM XL site-directed mutagenesis kit (Stratagene) with the corresponding Orai1 and/or Orai1-Orai3 chimeric constructs serving as a template. The same procedure was used for Orai3 (F160A and P254L). For C-terminal fluorescence labeling of human Orai1 (Orai1; accession number NM_032790, provided by the laboratory of A. Rao), the construct was cloned into the pEYFP-N1 (Clontech) expression vector via XhoI and BamHI restriction sites.

Human STIM1 (STIM1; accession number NM_003156) N-terminally ECFP-tagged was kindly provided by the laboratory of T. Meyer (Stanford University). pECFP-C1 STIM1 C terminus (aa 233–685 WT and L251S) was used as a template for generation of pECFP-OASF (WT and L251S) by introducing a stop codon at position 475 (aa 233–474) using the QuikChange XL site-directed mutagenesis kit (Stratagene). STIM1 fragment 344–449 (CRAC activation domain) was amplified via PCR, including an N-terminal KpnI and a C-terminal XbaI restriction site for cloning into the pECFP-C1 vector.

All clones were confirmed by sequence analysis.

Cell culture and transfection

Transient transfection of HEK 293 cells was performed (63) using either the TransFectin lipid reagent (Bio-Rad) or the TransPass transfection reagent (New England Biolabs). The CRISP/Cas9 STIM1 knockout HEK cells were kindly provided by M. Trebak (Penn State).

Electrophysiology

Electrophysiological recordings that assessed the characteristics of 2–3 constructs were carried out in paired comparison on the same day. Expression patterns and levels of the various constructs were carefully monitored by confocal fluorescence microscopy and were not significantly changed by the introduced mutations. Electrophysiological experiments were performed at 20–24 °C, using the patch-clamp technique in the whole-cell recording configuration. For STIM1/Orai as well as STIM1 C terminus/Orai current measurements, voltage ramps were usually applied every 5 s from a holding potential of 0 mV, covering a range of −90 to +90 mV over 1 s. Voltage step protocols were applied from a holding potential of 0 to −70 mV for 1.5 s to determine FCDI. The internal pipette solution for passive store depletion contained 3.5 mm MgCl2, 145 mm cesium methane sulfonate, 8 mm NaCl, 10 mm HEPES, 20 mm EGTA, pH 7.2. Extracellular solution consisted of 145 mm NaCl, 5 mm CsCl, 1 mm MgCl2, 10 mm HEPES, 10 mm glucose, 10 mm CaCl2, pH 7.4. Na+-DVF solution contained 150 mm NaCl, 10 mm HEPES, 10 mm glucose, and 10 mm EDTA, pH 7.4. Applied voltages were not corrected for the liquid junction potential, which was determined as +12 mV. All currents were leak-corrected by subtraction of the leak current that remained following 10 μm La3+ application.

Confocal fluorescence microscopy

Confocal microscopy for co-localization experiments was performed in a manner similar to that described previously (64). In brief, a QLC100 real-time confocal system (VisiTech International, Sunderland, UK) was used for recording fluorescence images connected to two Photometrics CoolSNAPHQ monochrome cameras (Roper Scientific) and a dual port adapter (dichroic: 505lp; cyan emission filter: 485/30; yellow emission filter: 535/50; Chroma Technology Corp.). This system was attached to an Axiovert 200M microscope (Zeiss, Jena, Germany) in conjunction with an argon ion multiwavelength (457, 488, and 514 nm) laser (Spectra Physics). The wavelengths were selected by an Acousto Optical tunable filter (VisiTech International). MetaMorph version 5.0 software (Universal Imaging Corp.) was used to acquire images and to control the confocal system. Illumination times for CFP and YFP images that were consecutively recorded with a minimum delay were about 900 ms.

Statistics

Results are presented as means ± S.E. calculated for the indicated number of experiments. Student's two-tailed t test was used for statistical comparison considering differences statistically significant at p < 0.05.

Author contributions

I. D. and C. R. conceived and coordinated the study and wrote the paper. I. D., C. B., A. K., and M. S. performed and analyzed electrophysiological experiments. M. M. carried out fluorescence microscopy experiments. C. B., M. F., and I. F. contributed to molecular biology. All authors reviewed the results and approved the final version of the manuscript.

Supplementary Material

Supporting Information

Acknowledgment

We thank S. Buchegger for excellent technical assistance.

This work was supported in part by the Austrian Science Fund (FWF) projects P25210 and P27641 (to I. D.), P28123 (to M. F.), P28498 (to M. M.), and P26067, P27263, and W 1250 (to C. R.). The authors declare that they have no conflicts of interest with the contents of this article.

This article contains Figs. S1–S9.

3
The abbreviations used are:
CRAC
Ca2+ release-activated Ca2+
STIM1
stromal interaction molecule 1
ER
endoplasmic reticulum
PM
plasma membrane
TM
transmembrane domain(s)
DVF
divalent-free
FCDI
fast Ca2+-dependent inactivation
ETON
extended transmembrane Orai N-terminal
aa
amino acids
OASF
Orai1-activating STIM1 fragment
CFP
cyan fluorescent protein
ECFP
enhanced CFP
YFP
yellow fluorescent protein
L2
loop2.

References

  • 1. Berridge M. J., Bootman M. D., and Roderick H. L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517–529 10.1038/nrm1155 [DOI] [PubMed] [Google Scholar]
  • 2. Berridge M. J., Lipp P., and Bootman M. D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21 10.1038/35036035 [DOI] [PubMed] [Google Scholar]
  • 3. Lee K. P., Yuan J. P., Hong J. H., So I., Worley P. F., and Muallem S. (2010) An endoplasmic reticulum/plasma membrane junction: STIM1/Orai1/TRPCs. FEBS Lett. 584, 2022–2027 10.1016/j.febslet.2009.11.078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Parekh A. B. (2008) Store-operated channels: mechanisms and function. J. Physiol. 586, 3033 10.1113/jphysiol.2008.156885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S. H., Tanasa B., Hogan P. G., Lewis R. S., Daly M., and Rao A. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179–185 10.1038/nature04702 [DOI] [PubMed] [Google Scholar]
  • 6. Liou J., Kim M. L., Heo W. D., Jones J. T., Myers J. W., Ferrell J. E. Jr, and Meyer T. (2005) STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 15, 1235–1241 10.1016/j.cub.2005.05.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Roos J., DiGregorio P. J., Yeromin A. V., Ohlsen K., Lioudyno M., Zhang S., Safrina O., Kozak J. A., Wagner S. L., Cahalan M. D., Veliçelebi G., and Stauderman K. A. (2005) STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 169, 435–445 10.1083/jcb.200502019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Zhang S. L., Yeromin A. V., Zhang X. H. F., Yu Y., Safrina O., Penna A., Roos J., Stauderman K. A., and Cahalan M. D. (2006) Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate Ca2+ release-activated Ca2+ channel activity. Proc. Natl. Acad. Sci. U.S.A. 103, 9357–9362 10.1073/pnas.0603161103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Cahalan M. D., and Chandy K. G. (2009) The functional network of ion channels in T lymphocytes. Immunol. Rev. 231, 59–87 10.1111/j.1600-065X.2009.00816.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Mercer J. C., Dehaven W. I., Smyth J. T., Wedel B., Boyles R. R., Bird G. S., and Putney J. W. Jr. (2006) Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J. Biol. Chem. 281, 24979–24990 10.1074/jbc.M604589200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Peinelt C., Vig M., Koomoa D. L., Beck A., Nadler M. J., Koblan-Huberson M., Lis A., Fleig A., Penner R., and Kinet J. P. (2006) Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat. Cell Biol. 8, 771–773 10.1038/ncb1435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Soboloff J., Spassova M. A., Tang X. D., Hewavitharana T., Xu W., and Gill D. L. (2006) Orai1 and STIM reconstitute store-operated calcium channel function. J. Biol. Chem. 281, 20661–20665 10.1074/jbc.C600126200 [DOI] [PubMed] [Google Scholar]
  • 13. Spassova M. A., Soboloff J., He L. P., Xu W., Dziadek M. A., and Gill D. L. (2006) STIM1 has a plasma membrane role in the activation of store-operated Ca2+ channels. Proc. Natl. Acad. Sci. U.S.A. 103, 4040–4045 10.1073/pnas.0510050103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., and Hogan P. G. (2006) Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230–233 10.1038/nature05122 [DOI] [PubMed] [Google Scholar]
  • 15. Yeromin A. V., Zhang S. L., Jiang W., Yu Y., Safrina O., and Cahalan M. D. (2006) Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443, 226–229 10.1038/nature05108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Wu M. M., Buchanan J., Luik R. M., and Lewis R. S. (2006) Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J. Cell Biol. 174, 803–813 10.1083/jcb.200604014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Vig M., Peinelt C., Beck A., Koomoa D. L., Rabah D., Koblan-Huberson M., Kraft S., Turner H., Fleig A., Penner R., and Kinet J. P. (2006) CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312, 1220–1223 10.1126/science.1127883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Calloway N., Vig M., Kinet J. P., Holowka D., and Baird B. (2009) Molecular clustering of STIM1 with Orai1/CRACM1 at the plasma membrane depends dynamically on depletion of Ca2+ stores and on electrostatic interactions. Mol. Biol. Cell 20, 389–399 10.1091/mbc.E07-11-1132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Barr V. A., Bernot K. M., Srikanth S., Gwack Y., Balagopalan L., Regan C. K., Helman D. J., Sommers C. L., Oh-Hora M., Rao A., and Samelson L. E. (2008) Dynamic movement of the calcium sensor STIM1 and the calcium channel Orai1 in activated T-cells: puncta and distal caps. Mol. Biol. Cell 19, 2802–2817 10.1091/mbc.E08-02-0146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Park C. Y., Hoover P. J., Mullins F. M., Bachhawat P., Covington E. D., Raunser S., Walz T., Garcia K. C., Dolmetsch R. E., and Lewis R. S. (2009) STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 136, 876–890 10.1016/j.cell.2009.02.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Cahalan M. D. (2009) STIMulating store-operated Ca2+ entry. Nat. Cell Biol. 11, 669–677 10.1038/ncb0609-669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Muik M., Frischauf I., Derler I., Fahrner M., Bergsmann J., Eder P., Schindl R., Hesch C., Polzinger B., Fritsch R., Kahr H., Madl J., Gruber H., Groschner K., and Romanin C. (2008) Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J. Biol. Chem. 283, 8014–8022 10.1074/jbc.M708898200 [DOI] [PubMed] [Google Scholar]
  • 23. Muik M., Fahrner M., Schindl R., Stathopulos P., Frischauf I., Derler I., Plenk P., Lackner B., Groschner K., Ikura M., and Romanin C. (2011) STIM1 couples to ORAI1 via an intramolecular transition into an extended conformation. EMBO J. 30, 1678–1689 10.1038/emboj.2011.79 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hoth M., and Niemeyer B. A. (2013) The neglected CRAC proteins: Orai2, Orai3, and STIM2. Curr. Top. Membr. 71, 237–271 10.1016/B978-0-12-407870-3.00010-X [DOI] [PubMed] [Google Scholar]
  • 25. Feske S., Skolnik E. Y., and Prakriya M. (2012) Ion channels and transporters in lymphocyte function and immunity. Nat. Rev. Immunol. 12, 532–547 10.1038/nri3233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Li Z., Lu J., Xu P., Xie X., Chen L., and Xu T. (2007) Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation. J. Biol. Chem. 282, 29448–29456 10.1074/jbc.M703573200 [DOI] [PubMed] [Google Scholar]
  • 27. McNally B. A., Somasundaram A., Jairaman A., Yamashita M., and Prakriya M. (2013) The C- and N-terminal STIM1 binding sites on Orai1 are required for both trapping and gating CRAC channels. J. Physiol. 591, 2833–2850 10.1113/jphysiol.2012.250456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Palty R., and Isacoff E. Y. (2016) Cooperative binding of stromal interaction molecule 1 (STIM1) to the N and C termini of calcium release-activated calcium modulator 1 (Orai1). J. Biol. Chem. 291, 334–341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Derler I., Plenk P., Fahrner M., Muik M., Jardin I., Schindl R., Gruber H. J., Groschner K., and Romanin C. (2013) The extended transmembrane Orai1 N-terminal (ETON) region combines binding interface and gate for Orai1 activation by STIM1. J. Biol. Chem. 288, 29025–29034 10.1074/jbc.M113.501510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Zheng H., Zhou M. H., Hu C., Kuo E., Peng X., Hu J., Kuo L., and Zhang S. L. (2013) Differential roles of the C and N termini of Orai1 protein in interacting with stromal interaction molecule 1 (STIM1) for Ca2+ release-activated Ca2+ (CRAC) channel activation. J. Biol. Chem. 288, 11263–11272 10.1074/jbc.M113.450254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Zhou Y., Cai X., Loktionova N. A., Wang X., Nwokonko R. M., Wang X., Wang Y., Rothberg B. S., Trebak M., and Gill D. L. (2016) The STIM1-binding site nexus remotely controls Orai1 channel gating. Nat. Commun. 7, 13725 10.1038/ncomms13725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Hou X., Pedi L., Diver M. M., and Long S. B. (2012) Crystal structure of the calcium release-activated calcium channel Orai. Science 338, 1308–1313 10.1126/science.1228757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Zhang S. L., Yeromin A. V., Hu J., Amcheslavsky A., Zheng H., and Cahalan M. D. (2011) Mutations in Orai1 transmembrane segment 1 cause STIM1-independent activation of Orai1 channels at glycine 98 and channel closure at arginine 91. Proc. Natl. Acad. Sci. U.S.A. 108, 17838–17843 10.1073/pnas.1114821108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. McNally B. A., Somasundaram A., Yamashita M., and Prakriya M. (2012) Gated regulation of CRAC channel ion selectivity by STIM1. Nature 482, 241–245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Derler I., Jardin I., and Romanin C. (2016) Molecular mechanisms of STIM/Orai communication. Am. J. Physiol. Cell Physiol. 310, C643–C662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Böhm J., Bulla M., Urquhart J. E., Malfatti E., Williams S. G., O'Sullivan J., Szlauer A., Koch C., Baranello G., Mora M., Ripolone M., Violano R., Moggio M., Kingston H., Dawson T., et al. (2017) ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy. Hum. Mutat. 38, 426–438 10.1002/humu.23172 [DOI] [PubMed] [Google Scholar]
  • 37. Endo Y., Noguchi S., Hara Y., Hayashi Y. K., Motomura K., Miyatake S., Murakami N., Tanaka S., Yamashita S., Kizu R., Bamba M., Goto Y., Matsumoto N., Nonaka I., and Nishino I. (2015) Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca2+ channels. Hum. Mol. Genet. 24, 637–648 10.1093/hmg/ddu477 [DOI] [PubMed] [Google Scholar]
  • 38. Srikanth S., Yee M. K., Gwack Y., and Ribalet B. (2011) The third transmembrane segment of orai1 protein modulates Ca2+ release-activated Ca2+ (CRAC) channel gating and permeation properties. J. Biol. Chem. 286, 35318–35328 10.1074/jbc.M111.265884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Palty R., and Isacoff E. Y. (2016) Cooperative binding of stromal interaction molecule 1 (STIM1) to the N and C termini of calcium release-activated calcium modulator 1 (Orai1). J. Biol. Chem. 291, 334–341 10.1074/jbc.M115.685289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Palty R., Stanley C., and Isacoff E. Y. (2015) Critical role for Orai1 C-terminal domain and TM4 in CRAC channel gating. Cell Res. 25, 963–980 10.1038/cr.2015.80 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Hoth M., and Penner R. (1992) Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355, 353–356 10.1038/355353a0 [DOI] [PubMed] [Google Scholar]
  • 42. Lis A., Peinelt C., Beck A., Parvez S., Monteilh-Zoller M., Fleig A., and Penner R. (2007) CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr. Biol. 17, 794–800 10.1016/j.cub.2007.03.065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Hoth M., and Penner R. (1993) Calcium release-activated calcium current in rat mast cells. J. Physiol. 465, 359–386 10.1113/jphysiol.1993.sp019681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Bakowski D., and Parekh A. B. (2002) Permeation through store-operated CRAC channels in divalent-free solution: potential problems and implications for putative CRAC channel genes. Cell Calcium 32, 379–391 10.1016/S0143416002001914 [DOI] [PubMed] [Google Scholar]
  • 45. Lepple-Wienhues A., and Cahalan M. D. (1996) Conductance and permeation of monovalent cations through depletion-activated Ca2+ channels (ICRAC) in Jurkat T cells. Biophys. J. 71, 787–794 10.1016/S0006-3495(96)79278-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Prakriya M., and Lewis R. S. (2006) Regulation of CRAC channel activity by recruitment of silent channels to a high open-probability gating mode. J. Gen. Physiol. 128, 373–386 10.1085/jgp.200609588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Prakriya M., and Lewis R. S. (2002) Separation and characterization of currents through store-operated CRAC channels and Mg2+-inhibited cation (MIC) channels. J. Gen. Physiol. 119, 487–507 10.1085/jgp.20028551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Su Z., Shoemaker R. L., Marchase R. B., and Blalock J. E. (2004) Ca2+ modulation of Ca2+ release-activated Ca2+ channels is responsible for the inactivation of its monovalent cation current. Biophys. J. 86, 805–814 10.1016/S0006-3495(04)74156-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Mullins F. M., and Lewis R. S. (2016) The inactivation domain of STIM1 is functionally coupled with the Orai1 pore to enable Ca2+-dependent inactivation. J. Gen. Physiol. 147, 153–164 10.1085/jgp.201511438 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Mullins F. M., Yen M., and Lewis R. S. (2016) Orai1 pore residues control CRAC channel inactivation independently of calmodulin. J. Gen. Physiol. 147, 137–152 10.1085/jgp.201511437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. DeHaven W. I., Smyth J. T., Boyles R. R., and Putney J. W. Jr. (2007) Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J. Biol. Chem. 282, 17548–17556 10.1074/jbc.M611374200 [DOI] [PubMed] [Google Scholar]
  • 52. Yamashita M., Navarro-Borelly L., McNally B. A., and Prakriya M. (2007) Orai1 mutations alter ion permeation and Ca2+-dependent fast inactivation of CRAC channels: evidence for coupling of permeation and gating. J. Gen. Physiol. 130, 525–540 10.1085/jgp.200709872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Dynes J. L., Amcheslavsky A., and Cahalan M. D. (2016) Genetically targeted single-channel optical recording reveals multiple Orai1 gating states and oscillations in calcium influx. Proc. Natl. Acad. Sci. U.S.A. 113, 440–445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Zweifach A., and Lewis R. S. (1995) Rapid inactivation of depletion-activated calcium current (ICRAC) due to local calcium feedback. J. Gen. Physiol. 105, 209–226 10.1085/jgp.105.2.209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Schindl R., Frischauf I., Bergsmann J., Muik M., Derler I., Lackner B., Groschner K., and Romanin C. (2009) Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. Proc. Natl. Acad. Sci. U.S.A. 106, 19623–19628 10.1073/pnas.0907714106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Lee K. P., Yuan J. P., Zeng W., So I., Worley P. F., and Muallem S. (2009) Molecular determinants of fast Ca2+-dependent inactivation and gating of the Orai channels. Proc. Natl. Acad. Sci. U.S.A. 106, 14687–14692 10.1073/pnas.0904664106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Nesin V., Wiley G., Kousi M., Ong E. C., Lehmann T., Nicholl D. J., Suri M., Shahrizaila N., Katsanis N., Gaffney P. M., Wierenga K. J., and Tsiokas L. (2014) Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc. Natl. Acad. Sci. U.S.A. 111, 4197–4202 10.1073/pnas.1312520111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Yen M., Lokteva L. A., and Lewis R. S. (2016) Functional analysis of Orai1 concatemers supports a hexameric stoichiometry for the CRAC channel. Biophys. J. 111, 1897–1907 10.1016/j.bpj.2016.09.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Bergsmann J., Derler I., Muik M., Frischauf I., Fahrner M., Pollheimer P., Schwarzinger C., Gruber H. J., Groschner K., and Romanin C. (2011) Molecular determinants within N terminus of Orai3 protein that control channel activation and gating. J. Biol. Chem. 286, 31565–31575 10.1074/jbc.M111.227546 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Lis A., Zierler S., Peinelt C., Fleig A., and Penner R. (2010) A single lysine in the N-terminal region of store-operated channels is critical for STIM1-mediated gating. J. Gen. Physiol. 136, 673–686 10.1085/jgp.201010484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Yamashita M., Yeung P. S., Ing C. E., McNally B. A., Pomès R., and Prakriya M. (2017) STIM1 activates CRAC channels through rotation of the pore helix to open a hydrophobic gate. Nat. Commun. 8, 14512 10.1038/ncomms14512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Gudlur A., Quintana A., Zhou Y., Hirve N., Mahapatra S., and Hogan P. G. (2014) STIM1 triggers a gating rearrangement at the extracellular mouth of the ORAI1 channel. Nat. Commun. 5, 5164 10.1038/ncomms6164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Derler I., Hofbauer M., Kahr H., Fritsch R., Muik M., Kepplinger K., Hack M. E., Moritz S., Schindl R., Groschner K., and Romanin C. (2006) Dynamic but not constitutive association of calmodulin with rat TRPV6 channels enables fine tuning of Ca2+-dependent inactivation. J. Physiol. 577, 31–44 10.1113/jphysiol.2006.118661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Singh A., Hamedinger D., Hoda J. C., Gebhart M., Koschak A., Romanin C., and Striessnig J. (2006) C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nat. Neurosci. 9, 1108–1116 10.1038/nn1751 [DOI] [PubMed] [Google Scholar]
  • 65. Fahrner M., Pandey S. K., Muik M., Traxler L., Butorac C., Stadlbauer M., Zayats V., Krizova A., Plenk P., Frischauf I., Schindl R., Gruber H. J., Hinterdorfer P., Ettrich R., Romanin C., and Derler I. (2018) Communication between N terminus and loop2 tunes Orai activation. J. Biol. Chem. 293, 1271–1285 10.1074/jbc.M117.812693 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES